191 related articles for article (PubMed ID: 24884156)
1. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.
Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156
[TBL] [Abstract][Full Text] [Related]
2. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
Pivarcsik T; Kiss MA; Rapuš U; Kljun J; Spengler G; Frank É; Turel I; Enyedy ÉA
Dalton Trans; 2024 Mar; 53(11):4984-5000. PubMed ID: 38406993
[TBL] [Abstract][Full Text] [Related]
3. Redox pathways in DNA oxidation: kinetic studies of guanine and sugar oxidation by para-substituted derivatives of oxoruthenium(IV).
Farrer BT; Thorp HH
Inorg Chem; 2000 Jan; 39(1):44-9. PubMed ID: 11229031
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and the effect of ligand planarity of [Ru(bpy)2L]2+ on DNA binding affinity.
Zhen QX; Ye BH; Zhang QL; Liu JG; Li H; Ji LN; Wang L
J Inorg Biochem; 1999 Jul; 76(1):47-53. PubMed ID: 10530006
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium(II) Polypyridyl-Based Photocages for an Anticancer Phytochemical Diallyl Sulfide: Comparative Dark and Photoreactivity Studies of Caged and Precursor Uncaged Complexes.
Mishra R; Saha A; Chatterjee P; Bhattacharyya A; Patra AK
Inorg Chem; 2023 Nov; 62(46):18839-18855. PubMed ID: 37930798
[TBL] [Abstract][Full Text] [Related]
6. Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes.
Nováková O; Kaspárková J; Vrána O; van Vliet PM; Reedijk J; Brabec V
Biochemistry; 1995 Sep; 34(38):12369-78. PubMed ID: 7547981
[TBL] [Abstract][Full Text] [Related]
7. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
[TBL] [Abstract][Full Text] [Related]
8. Stopped-flow analysis of Ru(bpy)3(3+) chemiluminescent reactions.
Shultz LL; Nieman TA
J Biolumin Chemilumin; 1998; 13(2):85-90. PubMed ID: 9633011
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cancer cell growth by ruthenium(II) arene complexes.
Morris RE; Aird RE; Murdoch Pdel S; Chen H; Cummings J; Hughes ND; Parsons S; Parkin A; Boyd G; Jodrell DI; Sadler PJ
J Med Chem; 2001 Oct; 44(22):3616-21. PubMed ID: 11606126
[TBL] [Abstract][Full Text] [Related]
10. A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug:
Lazić D; Scheurer A; Ćoćić D; Milovanović J; Arsenijević A; Stojanović B; Arsenijević N; Milovanović M; Rilak Simović A
Dalton Trans; 2021 Jun; 50(22):7686-7704. PubMed ID: 33982702
[TBL] [Abstract][Full Text] [Related]
11. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
Büchel GE; Gavriluta A; Novak M; Meier SM; Jakupec MA; Cuzan O; Turta C; Tommasino JB; Jeanneau E; Novitchi G; Luneau D; Arion VB
Inorg Chem; 2013 Jun; 52(11):6273-85. PubMed ID: 23659478
[TBL] [Abstract][Full Text] [Related]
12. Influence of diimine bidentate ligand in the nitrosyl and nitro terpyridine ruthenium complex on the HSA/DNA interaction and antiviral activity.
Bessas NC; Christine de Souza Arantes E; Cassani NM; Aquino Ruiz UE; Santos IA; Silva Martins DO; Costa Oliveira AL; Antoniucci GA; de Oliveira AHC; DeFreitas-Silva G; Gomes Jardim AC; Galvão de Lima R
Nitric Oxide; 2024 Jun; 147():26-41. PubMed ID: 38614230
[TBL] [Abstract][Full Text] [Related]
13. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway.
Chen L; Yu W; Tang H; Zhang S; Wang J; Ouyang Q; Guo M; Zhu X; Huang Z; Chen J
Metallomics; 2024 Jan; 16(1):. PubMed ID: 38183290
[TBL] [Abstract][Full Text] [Related]
14. [Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.
Garner RN; Gallucci JC; Dunbar KR; Turro C
Inorg Chem; 2011 Oct; 50(19):9213-5. PubMed ID: 21879748
[TBL] [Abstract][Full Text] [Related]
15. Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.
Wang F; Habtemariam A; van der Geer EP; Fernández R; Melchart M; Deeth RJ; Aird R; Guichard S; Fabbiani FP; Lozano-Casal P; Oswald ID; Jodrell DI; Parsons S; Sadler PJ
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18269-74. PubMed ID: 16352726
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent interaction of ruthenium(II) polypyridyl complexes with DNA probed by emission spectroscopy.
Kirsch-De Mesmaeker A; Orellana G; Barton JK; Turro NJ
Photochem Photobiol; 1990 Sep; 52(3):461-72. PubMed ID: 2284340
[TBL] [Abstract][Full Text] [Related]
17. Diastereoselective Synthesis, Spectroscopy, and Electrochemistry of Ruthenium(II) Complexes of Substituted Pyrazolylpyridine Ligands.
Luo Y; Potvin PG; Tse YH; Lever AB
Inorg Chem; 1996 Sep; 35(19):5445-5452. PubMed ID: 11666729
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.
Glans L; Ehnbom A; de Kock C; Martínez A; Estrada J; Smith PJ; Haukka M; Sánchez-Delgado RA; Nordlander E
Dalton Trans; 2012 Mar; 41(9):2764-73. PubMed ID: 22249579
[TBL] [Abstract][Full Text] [Related]
19. Novel family of [RuCp(N,N)(P)]
Teixeira RG; Mészáros JP; Matos B; Côrte-Real L; Xavier CPR; Fontrodona X; Garcia MH; Romero I; Spengler G; Vasconcelos MH; Tomaz AI; Enyedy ÉA; Valente A
Eur J Med Chem; 2023 Dec; 262():115922. PubMed ID: 37944388
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of OH radical-induced strand break formation of poly(U) by Ru(bpy)32+ or Ru(phen)32+ attached to the polynucleotide.
Tossi AB; Sun L; Görner H; Schulte-Frohlinde D
Int J Radiat Biol; 1995 Nov; 68(5):525-33. PubMed ID: 7490502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
